Tech Times
FDA Gives Nod To Praluent: New Class Of Cholesterol-Lowering Drug Is PriceyTech TimesPraluent could soon help patients with high cholesterol since the drug has received FDA approval. However, this new treatment method also comes at a hefty cost. (Photo : FDA | Flickr). Praluent has received approval from the Food and Drug ...New cholesterol drug OKdPhilly.comSanofi SA and Regeneron Pharmaceuticals Inc's Drug Cleared by FDANY City NewsReuters Health News SummaryDaily MailWeekly Observer -NYC Today -Yibada (English Edition)all 2 news articles »
Sunday, July 26, 2015
FDA Gives Nod To Praluent: New Class Of Cholesterol
By
Unknown
On
3:57 AM
Subscribe to:
Post Comments (Atom)